We characterized the tumor heterogeneity of lung cancer samples using our new end-to-end translational workflow based on the Phenoptics™ (rebranded as PhenoImager) platform.
Main Menu
We characterized the tumor heterogeneity of lung cancer samples using our new end-to-end translational workflow based on the Phenoptics™ (rebranded as PhenoImager) platform.